CSI Market
Sign In | Register

Addex Therapeutics Ltd (ADXN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ADXN Annual Balance Sheets →
A period-by-period view of the balance sheet from Addex Therapeutics Ltd to Dec 31 2024 helps clarify how Dec 31 2025's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents1.64
Cash & Short-term Investments1.00
Other Current Assets0.04
Total Current Assets1.68
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent4.68
Total Assets6.36
Liabilities
Other Liabilities, Current1.20
Total Current Liabilities1.20
Total Long-term Debt0.00
Total Liabilities1.60
Stockholders' Equity
Other Equity4.77
Common Stockholder's Equity4.77
Total Stockholder's Equity4.77
Liabilities & Stockholder's Equity6.36
4 historic quarters locked

Sign in to unlock the full Addex Therapeutics Ltd balance sheet history.

Sign In Create Free Account

About Addex Therapeutics Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-062447

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.